Efficacy, safety, and quality-of-life of treatments for acute relapses of multiple sclerosis: results from a literature review of randomized controlled trials.

Costello, Jessica; Njue, Annete; Lyall, Matthew; Heyes, Anne; Mahler, Nancy; Philbin, Michael; Nazareth, Tara

Costello, Jessica; Njue, Annete; Lyall, Matthew; Heyes, Anne; Mahler, Nancy; Philbin, Michael; Nazareth, Tara.

Afiliação

Costello J; Health Economics and Outcome Research/ Health Technology Assessment Services, RTI Health Solutions, Manchester, M20 2LS, UK.
Njue A; Health Economics and Outcome Research/ Health Technology Assessment Services, RTI Health Solutions, Manchester, M20 2LS, UK.
Lyall M; Health Economics and Outcome Research/ Health Technology Assessment Services, RTI Health Solutions, Manchester, M20 2LS, UK.
Heyes A; Health Economics and Outcome Research/ Health Technology Assessment Services, RTI Health Solutions, Manchester, M20 2LS, UK.
Mahler N; Health Economics and Outcome Research-Medical Science Liaison, Mallinckrodt Pharmaceuticals, Bedminister, NJ 07921, USA.
Philbin M; Health Economics and Outcome Research-Medical Science Liaison, Mallinckrodt Pharmaceuticals, Bedminister, NJ 07921, USA.
Nazareth T; Health Economics and Outcome Research, Mallinckrodt Pharmaceuticals, Bedminister, NJ 07921, USA.

Degener Neurol Neuromuscul Dis ; 9: 55-78, 2019.

Article em En | MEDLINE | ID: mdl-31308790

Palavras-chave

efficacy; multiple sclerosis relapse; safety; systematic literature review

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Guideline / Systematic_reviews Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google